ATA368277A - Verfahren zur herstellung neuer aryl- trifluoraethylamine, ihrer salze und optischen isomeren - Google Patents

Verfahren zur herstellung neuer aryl- trifluoraethylamine, ihrer salze und optischen isomeren

Info

Publication number
ATA368277A
ATA368277A AT773682A AT368277A ATA368277A AT A368277 A ATA368277 A AT A368277A AT 773682 A AT773682 A AT 773682A AT 368277 A AT368277 A AT 368277A AT A368277 A ATA368277 A AT A368277A
Authority
AT
Austria
Prior art keywords
trifluoraethylamine
salts
production
optical isomers
new aryl
Prior art date
Application number
AT773682A
Other languages
English (en)
Other versions
AT350062B (de
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Priority to AT420778A priority Critical patent/AT350579B/de
Priority to AT420578A priority patent/AT364838B/de
Priority to AT420678A priority patent/AT362380B/de
Publication of ATA368277A publication Critical patent/ATA368277A/de
Application granted granted Critical
Publication of AT350062B publication Critical patent/AT350062B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT368277A 1976-05-24 1977-05-23 Verfahren zur herstellung neuer aryl- trifluoraethylamine, ihrer salze und optischen isomeren AT350062B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT420778A AT350579B (de) 1976-05-24 1977-05-23 Verfahren zur herstellung neuer aryltrifluor- aethylamine, ihrer salze und optischen isomeren
AT420578A AT364838B (de) 1976-05-24 1978-06-09 Verfahren zur herstellung neuer alpha-aryltrifluoraethyl-(bzw. pentafluorpropyl-)amine
AT420678A AT362380B (de) 1976-05-24 1978-06-09 Verfahren zur herstellung neuer aryltrifluor- aethylamine ihrer salze und optischen isomeren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7615601A FR2358890A1 (fr) 1976-05-24 1976-05-24 Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (2)

Publication Number Publication Date
ATA368277A true ATA368277A (de) 1978-10-15
AT350062B AT350062B (de) 1979-05-10

Family

ID=9173528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT368277A AT350062B (de) 1976-05-24 1977-05-23 Verfahren zur herstellung neuer aryl- trifluoraethylamine, ihrer salze und optischen isomeren

Country Status (21)

Country Link
US (3) US4267345A (de)
JP (2) JPS584715B2 (de)
AR (2) AR219296A1 (de)
AT (1) AT350062B (de)
AU (1) AU517715B2 (de)
BE (1) BE854908A (de)
CH (1) CH625795A5 (de)
DE (1) DE2723464C2 (de)
ES (1) ES459086A1 (de)
FR (1) FR2358890A1 (de)
GB (2) GB1564268A (de)
GR (1) GR61659B (de)
HU (1) HU177039B (de)
IL (1) IL52137A (de)
NL (1) NL169182C (de)
NZ (1) NZ184175A (de)
OA (1) OA05668A (de)
PH (1) PH13880A (de)
PT (1) PT66584B (de)
SE (1) SE7705986L (de)
SU (2) SU725561A3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4348247A (en) * 1979-02-26 1982-09-07 Rockwell International Corporation Method of fabricating a reinforced tubular structure
ATE29494T1 (de) * 1983-08-11 1987-09-15 Synthelabo Indol-derivate, verfahren zu deren herstellung und deren therapeutische anwendung.
JPH06312412A (ja) * 1992-06-10 1994-11-08 Nippon Hume Pipe Co Ltd 模様付き複合コンクリート製品およびその成形方法
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
EP1385517A1 (de) * 2001-04-16 2004-02-04 University Of Virginia Patent Foundation Neue orale allgemeinanästhetika und metabolisch resistente antikonvulsiva
EP2070923A1 (de) 2007-12-11 2009-06-17 Bayer CropScience AG Insektizide Iminoheterocyclen
UY32940A (es) * 2009-10-27 2011-05-31 Bayer Cropscience Ag Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
AR085509A1 (es) 2011-03-09 2013-10-09 Bayer Cropscience Ag Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
IN2015DN01061A (de) 2012-08-17 2015-06-26 Bayer Cropscience Ag

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889351A (en) * 1956-05-25 1959-06-02 Pfizer & Co C Therapeutic agents
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3453284A (en) * 1966-01-19 1969-07-01 Du Pont Certain 2-(substituted-anilino)-2-oxazolines
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
US3622067A (en) * 1969-06-13 1971-11-23 Ok Partnership Ltd Document coder
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
USRE27133E (en) 1970-03-20 1971-06-01 Cdj)zco
GB1453703A (en) * 1972-12-28 1976-10-27 Science Union & Cie Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
US4102890A (en) * 1972-12-28 1978-07-25 Science-Union Et Cie, Societe Francaise De Recherche Medicale 2-Amino oxazolines and process for making the same
FR2269341B1 (de) * 1974-04-30 1978-07-28 Castaigne Sa
GB1475513A (en) * 1974-06-20 1977-06-01 Science Union & Cie Benzylamine derivatives process for science union et cie benzylamine derivatives process for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2537677A (en) 1978-11-30
PT66584B (fr) 1978-10-20
DE2723464A1 (de) 1977-12-08
FR2358890A1 (fr) 1978-02-17
FR2358890B1 (de) 1978-12-15
JPS584715B2 (ja) 1983-01-27
NL169182B (nl) 1982-01-18
PT66584A (fr) 1977-06-01
AU517715B2 (en) 1981-08-20
PH13880A (en) 1980-10-24
CH625795A5 (de) 1981-10-15
DE2723464C2 (de) 1983-08-11
AT350062B (de) 1979-05-10
GR61659B (en) 1978-12-05
US4267345A (en) 1981-05-12
US4315019A (en) 1982-02-09
JPS55127390A (en) 1980-10-02
GB1564269A (en) 1980-04-02
AR222022A1 (es) 1981-04-15
NL169182C (nl) 1982-06-16
BE854908A (fr) 1977-11-23
OA05668A (fr) 1981-05-31
SU791234A3 (ru) 1980-12-23
AR219296A1 (es) 1980-08-15
GB1564268A (en) 1980-04-02
SE7705986L (sv) 1977-11-25
ES459086A1 (es) 1978-04-16
US4315020A (en) 1982-02-09
IL52137A (en) 1982-01-31
NZ184175A (en) 1979-07-11
HU177039B (hu) 1981-06-28
SU725561A3 (ru) 1980-03-30
JPS5325565A (en) 1978-03-09
NL7705727A (nl) 1977-11-28
IL52137A0 (en) 1977-07-31

Similar Documents

Publication Publication Date Title
DD134642A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane
DD132869A5 (de) Verfahren zur herstellung neuer aminothiazolylazetamido-derivate
DD132585A5 (de) Verfahren zur herstellung neuer phenylaethylamine
AT350062B (de) Verfahren zur herstellung neuer aryl- trifluoraethylamine, ihrer salze und optischen isomeren
AT365177B (de) Verfahren zur herstellung neuer 2-formylchinoxalin-1,4-dioxid-zyanacetylhydrazo e
AT360551B (de) Verfahren zur herstellung asymmetrisch 1,3- -disubstituierter nitrosoharnstoffe
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
AT355036B (de) Verfahren zur herstellung neuer 1,2,6- thiadiazin-4-one
DD134351A5 (de) Verfahren zur herstellung neuer pyridobenzodiazepinonen
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
AT351014B (de) Verfahren zur herstellung des neuen 2-methyl- 4-trifluormethylanilins
ATA420778A (de) Verfahren zur herstellung neuer aryltrifluor- aethylamine, ihrer salze und optischen isomeren
AT351533B (de) Verfahren zur stereoselektiven herstellung neuer optisch aktiver 6a,10a-trans-1-hydroxy- 3-substituierter-6,6-dimethyl-6,6a,7,8,10,10a- hexahydro-9h-dibenzo(b,d)pyran-9-one
ATA420678A (de) Verfahren zur herstellung neuer aryltrifluor- aethylamine ihrer salze und optischen isomeren
ATA269779A (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
DD130331A1 (de) Verfahren zur herstellung von synthetischen mordenit
DD128270A5 (de) Verfahren zur herstellung neuer azofarbstoffe
ATA178679A (de) Verfahren zur herstellung neuer 2,3-dihydro-2 -oxo-thiophenderivate
ATA178579A (de) Verfahren zur herstellung neuer 2,3-dihydro -2-oxo-thiophenderivate
ATA8579A (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
ATA28576A (de) Verfahren zur herstellung neuer 1,3-dichloracetonoxim-o-alkyl-carbonate
AT351512B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
ATA656178A (de) Verfahren zur herstellung von neuen naphtyridinderivaten in form ihrer racemate oder ihrer optischen isomere und deren salzen
ATA534178A (de) Verfahren zur herstellung neuer aninosaeure- derivate, ihrer salze und optischen antipoden
ATA569779A (de) Verfahren zur herstellung neuer 1,4-dihydro- pyridinderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee